GSA Capital Partners’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,973
| Closed | -$273K | – | 2053 |
|
|
2025
Q1 | $273K | Buy |
+10,973
| New | +$273K | 0.02% | 1217 |
|
|
2024
Q2 | – | Sell |
-22,722
| Closed | -$664K | – | 1938 |
|
|
2024
Q1 | $664K | Sell |
22,722
-2,030
| -8% | -$59.3K | 0.05% | 711 |
|
|
2023
Q4 | $835K | Buy |
+24,752
| New | +$835K | 0.07% | 487 |
|
|
2023
Q2 | – | Sell |
-22,384
| Closed | -$913K | – | 1840 |
|
|
2023
Q1 | $913K | Sell |
22,384
-11,835
| -35% | -$483K | 0.09% | 363 |
|
|
2022
Q4 | $1.32M | Buy |
+34,219
| New | +$1.32M | 0.16% | 93 |
|
|
2020
Q2 | – | Sell |
-21,875
| Closed | -$733K | – | 988 |
|
|
2020
Q1 | $733K | Buy |
+21,875
| New | +$733K | 0.18% | 43 |
|
|
2019
Q4 | – | Sell |
-16,592
| Closed | -$632K | – | 1653 |
|
|
2019
Q3 | $632K | Sell |
16,592
-19,451
| -54% | -$741K | 0.09% | 406 |
|
|
2019
Q2 | $1.57M | Buy |
+36,043
| New | +$1.57M | 0.18% | 83 |
|
|
2019
Q1 | – | Sell |
-7,400
| Closed | -$318K | – | 1620 |
|
|
2018
Q4 | $318K | Buy |
+7,400
| New | +$318K | 0.04% | 809 |
|
|
2016
Q3 | – | Sell |
-29,900
| Closed | -$1.01M | – | 1912 |
|
|
2016
Q2 | $1.01M | Buy |
29,900
+19,800
| +196% | +$668K | 0.06% | 620 |
|
|
2016
Q1 | $535K | Buy |
+10,100
| New | +$535K | 0.03% | 973 |
|
|
2015
Q3 | – | Sell |
-18,550
| Closed | -$1.31M | – | 1966 |
|
|
2015
Q2 | $1.31M | Sell |
18,550
-8,700
| -32% | -$615K | 0.05% | 679 |
|
|
2015
Q1 | $2.42M | Buy |
27,250
+17,700
| +185% | +$1.57M | 0.1% | 242 |
|
|
2014
Q4 | $847K | Sell |
9,550
-3,821
| -29% | -$339K | 0.06% | 575 |
|
|
2014
Q3 | $1.3M | Buy |
+13,371
| New | +$1.3M | 0.07% | 356 |
|
|
2014
Q2 | – | Sell |
-32,197
| Closed | -$2.25M | – | 1925 |
|
|
2014
Q1 | $2.25M | Buy |
32,197
+16,392
| +104% | +$1.15M | 0.16% | 121 |
|
|
2013
Q4 | $909K | Buy |
15,805
+9,251
| +141% | +$532K | 0.07% | 425 |
|
|
2013
Q3 | $315K | Sell |
6,554
-11,983
| -65% | -$576K | 0.02% | 1114 |
|
|
2013
Q2 | $538K | Buy |
+18,537
| New | +$538K | 0.06% | 503 |
|